Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nexstim Plc (NXTMH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7431
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, therapy and neurosurgical planning purposes. Nexstim’s navigated brain therapy (NBT) system is based on same technology platform, focusing on the stimulation of targeted areas in the brain to improve and accelerate stroke rehabilitation. The company offers its products in the US, Finland and other European countries through subsidiaries. Nexstim is headquartered in Helsinki, Finland.

Nexstim Plc (NXTMH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nexstim Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nexstim Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Nexstim Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nexstim Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Nexstim Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Nexstim Plc, Medical Equipment, Deal Details 11
Partnerships 11
Nexstim to Enter into Distribution Agreement with Chinese Partner 11
Nexstim Enters into Co-Operation Agreement with Walton Centre 12
Equity Offering 13
Nexstim to Raise USD1.1 Million in Private Placement of Shares 13
Nexstim to Raise USD2 Million in Private Placement of Shares 14
Nexstim to Raise USD5.5 Million in Private Placement of Shares 15
Nexstim to Raise USD2.2 Million in Private Placement of Shares 17
Nexstim Raises USD5.8 Million in Private Placement of Shares 19
Nexstim Raises USD19 Million in IPO 20
Debt Offering 21
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 21
Nexstim Plc – Key Competitors 23
Nexstim Plc – Key Employees 24
Nexstim Plc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 16, 2018: Nexstim half-yearly report 1 January – 30 June 2018 (unaudited) 26
Feb 28, 2018: Nexstim Financial Statements Release 2017 28
Aug 17, 2017: Nexstim Half-yearly Report 1 January – 30 June 2016 (Unaudited) 30
Aug 16, 2017: Nexstim Half-Yearly Report 1 January – 30 June 2017 (Unaudited) 32
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 34
Feb 28, 2017: Nexstim: Financial Statement Release 2016 35
Corporate Communications 37
Oct 12, 2017: Change in Nexstim Management Team 37
Sep 26, 2017: Change in Nexstim’s Management Team 38
Aug 03, 2017: Changes in Nexstim’s Management Team 39
Jun 05, 2017: Nexstim Members of the Board Committees 40
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 41
Apr 24, 2017: Nexstim Appoints Hanna Kotola as VP of Legal Affairs 42
Mar 28, 2017: Nexstim: The decisions of the Board of Directors 43
Mar 09, 2017: Changes in Nexstim Management Team 44
Government and Public Interest 45
Jun 18, 2018: Nexstim SmartFocus TMS technology based therapy used across all university hospitals in Finland 45
Product News 46
Jan 31, 2017: Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system 46
Other Significant Developments 47
Oct 16, 2017: Nexstim is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US 47
May 08, 2017: Nexstim Terminates Market Making Agreement with Pareto Securities in Nasdaq First North Sweden 48
Apr 24, 2017: Aarhus University Hospital in Denmark Purchases NBS System from Nexstim 49
Mar 08, 2017: Nexstim announces signing of an Independent Selling Representative Agreement in the U.S. with Surgical Solutions 50
Jan 11, 2017: Nexstim announces signing of an Independent Selling Representative Agreements in U.S. 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Nexstim Plc, Medical Equipment, Key Facts, 2017 2
Nexstim Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nexstim Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nexstim Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Nexstim Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nexstim Plc, Deals By Market, 2012 to YTD 2018 9
Nexstim Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Nexstim to Enter into Distribution Agreement with Chinese Partner 11
Nexstim Enters into Co-Operation Agreement with Walton Centre 12
Nexstim to Raise USD1.1 Million in Private Placement of Shares 13
Nexstim to Raise USD2 Million in Private Placement of Shares 14
Nexstim to Raise USD5.5 Million in Private Placement of Shares 15
Nexstim to Raise USD2.2 Million in Private Placement of Shares 17
Nexstim Raises USD5.8 Million in Private Placement of Shares 19
Nexstim Raises USD19 Million in IPO 20
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 21
Nexstim Plc, Key Competitors 23
Nexstim Plc, Key Employees 24
Nexstim Plc, Subsidiaries 25

List of Figures
Nexstim Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nexstim Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nexstim Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nexstim Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nexstim Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nexstim Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Nexstim Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nexstim Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Defense Commissary Agency:企業の戦略的SWOT分析
    Defense Commissary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析
    LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cerner Corporation:企業の戦略・SWOT・財務情報
    Cerner Corporation - Strategy, SWOT and Corporate Finance Report Summary Cerner Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Polymedco Inc:医療機器:M&Aディール及び事業提携情報
    Summary Polymedco Inc (Polymedco) is a medical device company that manufactures and markets laboratory instruments, reagents and kits. The company offers FIT testing, ESR testing, chemistry testing instruments, oc-auto fit, oc-lights fit, oc-auto sensor, diana, oc-automicro 80, epi procolon, sediten …
  • Nippon Paper Industries Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Paper Industries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Paper Industries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MedinCell SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of the …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Unum Group:企業の戦略・SWOT・財務情報
    Unum Group - Strategy, SWOT and Corporate Finance Report Summary Unum Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Tupras (Turkish Petroleum Refineries Co):企業の戦略・SWOT・財務分析
    Tupras (Turkish Petroleum Refineries Co) - Strategy, SWOT and Corporate Finance Report Summary Tupras (Turkish Petroleum Refineries Co) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • NIKE Inc:戦略・SWOT・企業財務分析
    NIKE Inc - Strategy, SWOT and Corporate Finance Report Summary NIKE Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務情報
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep T …
  • Bayer AG (BAYN):企業の財務・戦略的SWOT分析
    Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Habib’s:企業の戦略・SWOT・財務分析
    Habib's - Strategy, SWOT and Corporate Finance Report Summary Habib's - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Clinical Innovations LLC:医療機器:M&Aディール及び事業提携情報
    Summary Clinical Innovations LLC (Clinical Innovations), a portfolio company of EQT AB, is a medical device company that researches and manufactures healthcare products to improve the lives of mothers and their babies. The company focuses on labor, delivery and neonatal intensive care. Its major pro …
  • Taconic Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company’s products include taconic transgenic mouse models, emerging models, cryopreserved models, traditional models, diet induced obese, …
  • Inform Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務情報
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Microchip Technology Incorporated:企業のM&A・事業提携・投資動向
    Microchip Technology Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microchip Technology Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆